Security key
805111101
CUSIP: 805111101
Security key
805111101
Report period
Q1 2025
Institutions
133
Top holders
10
Broader feeds
Reporting periods
Recent filing periods:
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Rank 1 holder
Rank 2 holder
Rank 3 holder
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Fund II, L.P. |
13D/G
|
10%
|
$55,969,975
17,600,621 shares
|
$0 | 25 Mar 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
13F
Company
|
3.2%
|
$17,431,660
5,481,654 shares
|
$0 | 31 Dec 2024 |
| NEA Management Company, LLC |
13F
Company
|
12%
|
$75,126,780
24,471,264 shares
|
— | 31 Dec 2024 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
6.9%
|
$44,715,953
14,565,457 shares
|
— | 31 Dec 2024 |
| TCG Crossover Management, LLC |
13F
Company
|
5.9%
|
$37,951,969
12,362,205 shares
|
— | 31 Dec 2024 |
| Vestal Point Capital, LP |
13F
Company
|
5.1%
|
$33,079,250
10,775,000 shares
|
— | 31 Dec 2024 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Investor-level positions for this CUSIP, loaded as an interactive table.
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).